Table 5.

Prognostic factors identified via multivariate analysis for metastatic renal cell carcinoma in patients with pancreas metastases.

Study	Year	Study Description	Patient #	Prognostic Factors	OS HR/OR (95% CI)	p-value
Santoni et al.	2015	Retrospective, Multi-center	103	MSKCC risk group	HR 5.14 (0.98–27.0)	0.04
Shin et al.	2021	Retrospective, Multi-center	300	Intermediate Heng risk group	HR 2.614 (1.386–4.930)	0.003
				T-stage 4	HR 27.380 (3.166–236.773)	0.003
				Pancreatic MTX	HR 0.482 (0.252–0.921)	0.027

OS, overall survival; HR, hazard ratio; OR, odds ratio; MSKCC, Memorial Sloan Kettering Cancer Center; MTX, metastasectomy.